Study to Evaluate the Effect of Food on the Pharmacokinetics of BMS-626529

Exclusion Criteria

• •Any significant acute or chronic medical illness as determined by the investigator
• •Current or recent (within 3 months of study drug administration) gastrointestinal disease that could impact upon the absorption of study drug
• •Any major surgery within 4 weeks of study drug administration
• •Any gastrointestinal surgery that could impact upon the absorption of study drug
• •Inability to tolerate oral medication
• •Recent (within 6 months of study drug administration) history of smoking or current smokers
• •Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, electrocardiogram (ECG) or clinical laboratory determinations beyond what is consistent with the target population
• •Any of the following on 12-lead ECG prior to study drug administration, confirmed by repeat:
• •* PR ≥ 210 msec
• •* QRS ≥ 120 msec
• •* QT ≥ 500 msec
• •* QTcF ≥ 450 msec
• •* Positive urine screen for drugs of abuse
• •Positive blood screen for hepatitis C antibody, hepatitis B surface antigen, or Human Immunodeficiency Virus-1 (HIV-1), -2 antibodies, and HIV-1 RNA